Core Viewpoint - Dengkang Dental (001328) reported strong financial performance for the first half of 2025, with both revenue and net profit showing significant year-on-year growth, indicating a positive trend in the company's operations and market position [1]. Financial Performance - Total revenue reached 842 million yuan, a year-on-year increase of 19.72% [1]. - Net profit attributable to shareholders was 85.16 million yuan, up 17.59% compared to the previous year [1]. - In Q2 2025, revenue was 411 million yuan, reflecting a 20.11% increase year-on-year, while net profit for the quarter was 42.00 million yuan, up 19.66% [1]. - Gross margin improved to 52.61%, a rise of 12.1% year-on-year, while net margin slightly decreased to 10.12%, down 1.78% [1]. - Total operating expenses (sales, management, and financial expenses) amounted to 330 million yuan, accounting for 39.23% of revenue, an increase of 17.55% year-on-year [1]. Key Financial Ratios - Earnings per share (EPS) increased to 0.49 yuan, a growth of 16.67% year-on-year [1]. - Operating cash flow per share rose to 0.38 yuan, up 22.86% year-on-year [1]. - The company's return on invested capital (ROIC) for the previous year was 10.56%, indicating average capital returns [3]. Fund Holdings - The largest fund holding Dengkang Dental shares is the Xinao Quality Return Mixed Fund, which holds 1.4545 million shares [5]. - Other notable funds include the Bosera Huirong Return Mixed Fund and Huabao Kang Consumer Products Fund, both of which have recently increased their positions in Dengkang Dental [5].
登康口腔2025年中报简析：营收净利润同比双双增长